- Home
- HMY vs HIMS Comparison
HMY vs HIMS Comparison
Compare HMY & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMY
- HIMS
- Stock Information
- Founded
- HMY 1950
- HIMS 2017
- Country
- HMY South Africa
- HIMS United States
- Employees
- HMY N/A
- HIMS N/A
- Industry
- HMY Precious Metals
- HIMS Medical/Nursing Services
- Sector
- HMY Basic Materials
- HIMS Health Care
- Exchange
- HMY Nasdaq
- HIMS Nasdaq
- Market Cap
- HMY 12.4B
- HIMS 12.2B
- IPO Year
- HMY N/A
- HIMS N/A
- Fundamental
- Price
- HMY $18.88
- HIMS $38.76
- Analyst Decision
- HMY Buy
- HIMS Hold
- Analyst Count
- HMY 3
- HIMS 12
- Target Price
- HMY $12.20
- HIMS $42.80
- AVG Volume (30 Days)
- HMY 5.0M
- HIMS 31.5M
- Earning Date
- HMY 01-01-0001
- HIMS 11-03-2025
- Dividend Yield
- HMY 0.93%
- HIMS N/A
- EPS Growth
- HMY 67.74
- HIMS 20.76
- EPS
- HMY 1.29
- HIMS 0.54
- Revenue
- HMY $4,161,584,110.00
- HIMS $2,210,958,000.00
- Revenue This Year
- HMY $35.41
- HIMS $61.73
- Revenue Next Year
- HMY $9.60
- HIMS $19.43
- P/E Ratio
- HMY $13.92
- HIMS $74.04
- Revenue Growth
- HMY 20.39
- HIMS 78.02
- 52 Week Low
- HMY $7.97
- HIMS $19.15
- 52 Week High
- HMY $22.25
- HIMS $72.98
- Technical
- Relative Strength Index (RSI)
- HMY 60.29
- HIMS 31.48
- Support Level
- HMY $15.14
- HIMS $39.34
- Resistance Level
- HMY $16.57
- HIMS $42.70
- Average True Range (ATR)
- HMY 0.61
- HIMS 2.78
- MACD
- HMY 0.12
- HIMS -0.66
- Stochastic Oscillator
- HMY 94.61
- HIMS 3.24
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
About HIMS Hims & Hers Health Inc.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.